Patents by Inventor Shuguang LIN

Shuguang LIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-human ADRB3 monoclonal antibody and application thereof in disease diagnosis and treatment
    Patent number: 11524073
    Abstract: The present invention discloses an application of a ?3 adrenergic receptor (ADRB3) as a marker for detecting a plurality of diseases, and an application of anti-human ADRB3 monoclonal antibody in diagnosing a disease and preparing a drug for treating the disease. The present invention finds through research that the ADRB3 is a key receptor in nerve-endocrine-immunoregulatory network, and an ADRB3-mediated signaling pathway regulates proliferation and differentiation of neutrophils, lymphocytes and tumor cells. Under normal circumstances, the ADRB3 maintains the non-specific immunocompetence and specific immunocompetence of an organism, and eliminates pathogenic microorganisms and aged organism tissues to play a role in protecting the organism and anti-aging. Under pathological conditions, excessive activation of the signaling pathway will cause systemic chronic inflammation, and destroy immune homeostasis.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: December 13, 2022
    Inventors: Meng Zheng, Shuguang Lin
  • Method for manufacturing textile waste into fiber grade polyester chips applicable to textile processing
    Publication number: 20200190280
    Abstract: The present invention provides a method for manufacturing textile waste into fiber grade polyester chips applicable to textile processing. The method comprises textile waste crushing, alcoholysis, filtering and separation, cooling crystallization, pressing, decoloration, distillation purification, preheating, prepolycondensation, polycondensation, cooling strip casting, and cutting into particles. By reducing textile waste to high purity bis(2-hydroxyethyl)terephthalate (hereinafter referred to as BHET), fiber grade polyester chips applicable to textile processing are re-manufactured. Thus, efficient recycling is achieved.
    Type: Application
    Filed: May 4, 2018
    Publication date: June 18, 2020
    Inventors: Shuguang LIN, Xingguang DONG, Junsheng LUO, Zhengqi ZHOU
  • ANTI-HUMAN ADRB3 MONOCLONAL ANTIBODY AND APPLICATION THEREOF IN DISEASE DIAGNOSIS AND TREATMENT
    Publication number: 20180355037
    Abstract: The present invention discloses an application of a J33 adrenergic receptor (ADRB3) as a marker for detecting a plurality of diseases, and an application of anti-human ADRB3 monoclonal antibody in diagnosing a disease and preparing a drug for treating the disease. The present invention finds through research that the ADRB3 is a key receptor in nerve-endocrine-immunoregulatory network, and an ADRB3-mediated signaling pathway regulates proliferation and differentiation of neutrophils, lymphocytes and tumor cells. Under normal circumstances, the ADRB3 maintains the non-specific immunocompetence and specific immunocompetence of an organism, and eliminates pathogenic microorganisms and aged organism tissues to play a role in protecting the organism and anti-aging. Under pathological conditions, excessive activation of the signaling pathway will cause systemic chronic inflammation, and destroy immune homeostasis.
    Type: Application
    Filed: March 23, 2018
    Publication date: December 13, 2018
    Inventors: Meng ZHENG, Shuguang LIN
  • Use of adrenergic beta-E-receptor blockers in cancer treatment
    Patent number: 9622996
    Abstract: A method for treating an cancer disease is disclosed comprising administering to a subject a pharmaceutical composition comprising an adrenergic beta-3-receptor blocker.
    Type: Grant
    Filed: January 30, 2013
    Date of Patent: April 18, 2017
    Inventors: Shuguang Lin, Meng Zheng
  • Use of adrenergic beta-3-receptor agonists in anti-aging
    Patent number: 8906955
    Abstract: A method for treating an aging-related disease is disclosed comprising administering to a subject a pharmaceutical composition comprising an adrenergic beta-3-receptor agonist.
    Type: Grant
    Filed: January 30, 2013
    Date of Patent: December 9, 2014
    Inventors: Shuguang Lin, Meng Zheng
  • USE OF ADRENERGIC BETA-3-RECEPTOR AGONISTS IN ANTI-AGING
    Publication number: 20130197074
    Abstract: A method for treating an aging-related disease is disclosed comprising administering to a subject a pharmaceutical composition comprising an adrenergic beta-3-receptor agonist.
    Type: Application
    Filed: January 30, 2013
    Publication date: August 1, 2013
    Inventors: Shuguang LIN, Meng ZHENG
  • USE OF ADRENERGIC BETA-E-RECEPTOR BLOCKERS IN CANCER TREATMENT
    Publication number: 20130197091
    Abstract: A method for treating an cancer disease is disclosed comprising administering to a subject a pharmaceutical composition comprising an adrenergic beta-3-receptor blocker.
    Type: Application
    Filed: January 30, 2013
    Publication date: August 1, 2013
    Inventors: Shuguang LIN, Meng ZHENG